1. Home
  2. GSM vs DNTH Comparison

GSM vs DNTH Comparison

Compare GSM & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferroglobe PLC

GSM

Ferroglobe PLC

HOLD

Current Price

$4.83

Market Cap

856.6M

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$38.08

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSM
DNTH
Founded
2015
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
856.6M
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GSM
DNTH
Price
$4.83
$38.08
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$6.00
$68.00
AVG Volume (30 Days)
872.7K
661.6K
Earning Date
02-18-2026
11-05-2025
Dividend Yield
1.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,373,244,000.00
$3,078,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$22.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.97
$13.37
52 Week High
$5.74
$45.46

Technical Indicators

Market Signals
Indicator
GSM
DNTH
Relative Strength Index (RSI) 60.78 39.82
Support Level $4.53 $35.84
Resistance Level $4.95 $43.40
Average True Range (ATR) 0.18 1.94
MACD 0.01 -0.77
Stochastic Oscillator 80.22 27.21

Price Performance

Historical Comparison
GSM
DNTH

About GSM Ferroglobe PLC

Ferroglobe PLC provides silicon-based alloys and specialty metals. It produces silicon metal and silicon and manganese-based alloy, serving customers in the specialty chemical, aluminum, solar, steel, and ductile iron foundry industries. The company's business segments include North America- Silicon, North America -Silicon Alloys; Europe Manganese; Europe Silicon Metals; Europe -Silicon Alloys, South Africa Silicon Metals, South Africa-Silicon Alloys, and Other segments The primary raw materials company uses to produce its electrometallurgy products includes its coal and quartz mining operations and its silicon metal and ferroalloy production.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: